Pharmacologic and Chemical Adjuvants in Tumor Virotherapy

This publication has 269 references indexed in Scilit:

• Phase Ib Trial of Oncolytic Herpes Virus G207 Shows Safety of Multiple Injections and Documents Viral Replication
  Molecular Therapy, 2009
• Hypoxia Enhances the Replication of Oncolytic Herpes Simplex Virus
  Molecular Therapy, 2009
• Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM
  Molecular Therapy, 2009
• Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells
  Cancer Gene Therapy, 2008
• Oncolytic HSV-1 Infection of Tumors Induces Angiogenesis and Upregulates CYR61
  Molecular Therapy, 2008
• Trichostatin A and Oncolytic HSV Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects
  Molecular Therapy, 2008
• Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression
  Published by Elsevier ,2008
• Cyclophosphamide Increases Transgene Expression Mediated by an Oncolytic Adenovirus in Glioma-Bearing Mice Monitored by Bioluminescence Imaging
  Molecular Therapy, 2006
• Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
  Cancer Immunology, Immunotherapy, 2006
• Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation
  Nature Medicine, 2003